Addex Therapeutics Ltd logo

Addex Therapeutics Ltd - ADR

NAS:ADXN (Switzerland)   ADR
$ 8.10 +0.09 (+1.12%) 07:08 PM EST
At Loss
Volume:
700.00
Avg Vol (2M):
3.11K
Trade In:
Volume:
700.00
At Loss
Avg Vol (2M):
3.11K

Business Description

Description
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
Name Current Vs Industry Vs History
Cash-To-Debt 46.57
Equity-to-Asset -0.41
Debt-to-Equity -0.03
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -160.42
Distress
Grey
Safe
Beneish M-Score -8.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 28.66
9-Day RSI 39.92
14-Day RSI 41.66
6-1 Month Momentum % 15.6
12-1 Month Momentum % -31.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.71
Quick Ratio 0.71
Cash Ratio 0.35
Days Sales Outstanding 48.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -66.5
Shareholder Yield % -1.28
Name Current Vs Industry Vs History
Operating Margin % -644.68
Net Margin % -835.39
FCF Margin % -581.99
ROE % -403.8
ROA % -184.75
ROIC % -1082.25
ROC (Joel Greenblatt) % -3400.31
ROCE % -295.03

Financials (Next Earnings Date:2024-08-18 Est.)

ADXN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ADXN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Addex Therapeutics Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.505
EPS (TTM) ($) -17.547
Beta 1.47
Volatility % 100.59
14-Day RSI 41.66
14-Day ATR ($) 0.361057
20-Day SMA ($) 8.13057
12-1 Month Momentum % -31.52
52-Week Range ($) 5 - 27.9
Shares Outstanding (Mil) 1.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Addex Therapeutics Ltd Filings

Filing Date Document Date Form
No Filing Data

Addex Therapeutics Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Addex Therapeutics Ltd Frequently Asked Questions

What is Addex Therapeutics Ltd(ADXN)'s stock price today?
The current price of ADXN is $8.10. The 52 week high of ADXN is $27.90 and 52 week low is $5.00.
When is next earnings date of Addex Therapeutics Ltd(ADXN)?
The next earnings date of Addex Therapeutics Ltd(ADXN) is 2024-08-18 Est..
Does Addex Therapeutics Ltd(ADXN) pay dividends? If so, how much?
Addex Therapeutics Ltd(ADXN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1